Julie A. Lofgren - Concepedia

Author

Julie A. Lofgren

Amgen (United States)

Also Known As

J A Lofgren, Julie A Lofgren, Julie A. Lofgren, Julie Lofgren

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)PDL BioPharma (United States)

About

Julie A. Lofgren is an author at Amgen (United States) specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	225
2	Cell Biology	2	2	159
3	Immunology	2	2	131
4	Natural Sciences	1	1	54
5	Biochemistry	1	1	54

Julie A. Lofgren

Publications

443

Citations

H-Index

Page 1

	Year	Citations
Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing Sandra L. Ross, Marika Sherman, Patricia McElroy, PLoS ONE ImmunologyImmunoeditingImmunodominanceImmunologic MechanismAntigen Processing	2017	105
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways Anne Y. Saiki, Sean Caenepeel, Dongyin Yu, Oncotarget	2014	55
Binding Interaction of the Heregulinβ egf Domain with ErbB3 and ErbB4 Receptors Assessed by Alanine Scanning Mutagenesis Jennifer T. Jones, Marcus Ballinger, Paul I. Pisacane, Journal of Biological Chemistry Protein AssemblyMolecular BiologyHeregulinβ Egf DomainAnalytical UltracentrifugationIndividual Residues	1998	54
Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage Display Marcus Ballinger, Jennifer T. Jones, Julie A. Lofgren, Journal of Biological Chemistry	1998	47
Kinetic Mechanism of AKT/PKB Enzyme Family Xiaoling Zhang, Shiwen Zhang, Harvey Yamane, Journal of Biological Chemistry	2006	41
A potential role for activated HER-2 in prostate cancer. David B. Agus, Robert W. Akita, William D. Fox, PubMed	2000	41
Heregulins and the ErbB-2/3/4 receptors in gliomas Manfred Westphal, Leonie Meima, Éva Szönyi, Journal of Neuro-Oncology	1997	34
Analysis of Heregulin-Induced ErbB2 Phosphorylation with a High-Throughput Kinase Receptor Activation Enzyme-Linked Immunosorbant Assay M D Sadick, Mark X. Sliwkowski, Andrew Nuijens, Analytical Biochemistry Signal TransductionMolecular PhysiologySignaling PathwayG Protein-coupled ReceptorHeregulin-induced Erbb2 Phosphorylation	1996	26
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics Qingping Zeng, Matthew P. Bourbeau, G. Erich Wohlhieter, Bioorganic & Medicinal Chemistry Letters MedicinePotential Cancer TherapeuticsPharmacotherapyAnti-cancer AgentPharmacology	2010	23
Azole-based inhibitors of AKT/PKB for the treatment of cancer Qingping Zeng, John G. Allen, Matthew P. Bourbeau, Bioorganic & Medicinal Chemistry Letters OncologyMedicinePharmacotherapyAzole-based InhibitorsAnti-cancer Agent	2010	17

Page 1